More delay for Boston biolab

Additional safety studies for Boston's planned Biosafety Level 4 lab, demanded by the Massachusetts Supreme Court last year, will further delay the opening of the facility, according to court documents filed by the NIH this week. In November, 2007, an outside scientific panel linkurl:concluded;http://www.the-scientist.com/blog/display/53944/ that the NIH had flubbed the safety evaluations for the lab, and in December, the Massachusetts Supreme Court linkurl:ruled;http://www.the-scientist.com/bl

Written byAlla Katsnelson
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Additional safety studies for Boston's planned Biosafety Level 4 lab, demanded by the Massachusetts Supreme Court last year, will further delay the opening of the facility, according to court documents filed by the NIH this week. In November, 2007, an outside scientific panel linkurl:concluded;http://www.the-scientist.com/blog/display/53944/ that the NIH had flubbed the safety evaluations for the lab, and in December, the Massachusetts Supreme Court linkurl:ruled;http://www.the-scientist.com/blog/display/54019/ that further safety studies were needed before the lab could open. According to the court documents, the NIH estimates it will release the results of the new study "on or before April 30, 2009." A lawyer for the Conservation Law Foundation, which linkurl:sued the NIH;http://www.the-scientist.com/news/display/23468/ in 2006 to stop the lab, told the Boston Globe in an linkurl:article today;http://www.boston.com/news/health/blog/2008/01/federal_review.html that the delays could mean that the lab won't be able to open until early 2010. University spokeswoman Ellen Berlin told The Scientist that BU "completely supports" the agency's further safety evaluation, and that it was too soon to estimate the timing for the biolab's opening.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies